The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (Review)-Reference-Cited by-同舟云学术

The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (Review)

Published:2021-05-02 Issue:1 Volume:22 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Ke Lingling¹,Li Qing²,Song Jingwei²,Jiao Wei²,Ji Aidong³,Chen Tongkai²,Pan Huafeng²,Song Yafang²

Affiliation:

1. cience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510405, P.R. China

2. Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510405, P.R. China

3. Clinical Medical College of Acupuncture, Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragaloside IV protects against autoimmune myasthenia gravis in rats via regulation of mitophagy and apoptosis;Molecular Medicine Reports;2024-05-24

2. Nanodrug Delivery Systems for Myasthenia Gravis: Advances and Perspectives;Pharmaceutics;2024-05-11

3. SIRT1 and ZNF350 as novel biomarkers for osteoporosis: a bioinformatics analysis and experimental validation;Molecular Biology Reports;2024-04-18

4. Defective autophagy and autophagy activators in myasthenia gravis: a rare entity and unusual scenario;Autophagy;2024-03-06

5. New Insights into Antioxidant Peptides: An Overview of Efficient Screening, Evaluation Models, Molecular Mechanisms, and Applications;Antioxidants;2024-02-05